Advertisement

Topics

Pear Therapeutics, Inc. Company Profile

17:26 EST 19th January 2019 | BioPortfolio

Pear Therapeutics is the leader in prescription digital therapeutics. We aim to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurological conditions. Our lead product, reSET®, treats Substance Use Disorder and was the first prescription digital therapeutic to receive marketing authorization from the FDA to treat disease. Pear’s second product, reSET-O™, for the treatment of Opioid Use Disorder, received marketing clearance from the FDA in December 2018. For more information, visit us at www.peartherapeutics.com.


News Articles [693 Associated News Articles listed on BioPortfolio]

Pear Therapeutics' app wins FDA clearance to help treat opioid abuse

Pear Therapeutics has secured clearance from the FDA to market its reSET-O mobile app for use in increasing retention of indi -More- 

Pear Therapeutics App Gets FDA Nod for Treating Opioid Abuse

Doctors and other caregivers have a new weapon to combat the opioid epidemic. But it’s not a pharmaceutical drug—it’s a mobile app. This week, the FDA cleared “reSET-O,” ...

Pear Therapeutics closes funding round at $64M

A Series C funding round led by Temasek has pulled in $64 million for Pear Therapeutics.  -More- 

Pear, Novartis unit debut digital substance use disorder treatment

Pear Therapeutics and Novartis division Sandoz have released reSET, a software-only therapeutic cleared by the FDA for treati -More- 

Pear Therapeutics to Present at Canaccord Genuity 38th Annual Growth Conference

Pear Therapeutics, Inc., the leader in prescription digital therapeutics, today announced that Corey McCann, M.D., Ph.D., President and CEO, will present at the Canaccord Genuity ...

Pear Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference

Pear Therapeutics, Inc., the leader in prescription digital therapeutics, today announced that Corey McCann, M.D., Ph.D., President and CEO, will present at the 37th Annual...

Pear Therapeutics to Participate in Evercore ISI HEALTHCONx Conference

Pear Therapeutics, Inc., the leader in prescription digital therapeutics, today announced that Christopher D.T. Guiffre, J.D., M.B.A., Chief Financial Officer and Chief Ope...

Sandoz, Pear Therapeutics launch reSET-O in US to treat OUD

The reSET-O, cleared by the US Food and Drug Administration (FDA) in December, is immediately available. The reSET-O prescription digital therapeutic (PDT) is a 12-week cognitive behavioral therapy T...

Drugs and Medications [85 Associated Drugs and Medications listed on BioPortfolio]

Pineapple pear antibacterial foaming handwash [SJ Creations, Inc.]

PINEAPPLE PEAR ANTIBACTERIAL FOAMING HAND WASH

Fresh pear [Blue Cross Laboratories, Inc. ]

Fresh Pear Antibacterial foaming hand soap

Sugared pear antibacterial hand sanitizer [Enchante Accessories]

SUGARED PEAR SCENTED ANTIBACTERIAL HAND SANITIZER

Sun shades [Melaleuca, Inc.]

Sun Shades Brandied Pear Lip Balm Content of Label

Lady speed stick [Colgate-Palmolive Company]

satin pear lady Speed Stick

PubMed Articles [508 Associated PubMed Articles listed on BioPortfolio]

Genome-wide Identification, Evolution, and Expression Analysis of the KT/HAK/KUP Family in Pear.

Here, we identified 20 K+ transporter genes in pear (P. bretschneideri) using genome-wide analysis. Their gene structure, chromosomal distribution, conserved motifs, phylogenetics, duplication events,...

Pollen trapping and sugar syrup feeding of honey bee (Hymenoptera: Apidae) enhance pollen collection of less preferred flowers.

Pear (Pyrus bretschneideri) is characterized by being self-incompatible and dependent on cross-pollination to set fruit. Honeybee (Apis mellifera) is considered the most important pollinator of pear. ...

Developmental and transcriptomal responses to seasonal dietary shifts in the cactophilic Drosophila mojavensis of North America.

Drosophila mojavensis normally breeds in necrotic columnar cactus, but they also feed and breed in Opuntia fruit (prickly pear) which serves as a seasonal resource. The prickly pear fruits are much di...

Identification and comparative analysis of the MCU gene family in pear and its functions during fruit ripening.

Mitochondrial calcium uniporter (MCU) plays an important role in cell senescence and aging in mammals. However, the function of MCU homologs during the ripening and senescence of postharvest fruit had...

Molecular identification, phylogenomic characterization and expression patterns analysis of the LIM (LIN-11, Isl1 and MEC-3 domains) gene family in pear (Pyrus bretschneideri) reveal its potential role in lignin metabolism.

Lignin is the main component of stone cells, which are a key factor in determining pear quality. Therefore, modification of lignin biosynthesis has important implications for regulating stone cell for...

Clinical Trials [171 Associated Clinical Trials listed on BioPortfolio]

Study of Efficacy of PEAR-004 in Schizophrenia

The purpose of the study is to determine in patients currently being administered antipsychotic pharmacotherapy whether PEAR-004 can further reduce symptoms of schizophrenia as measured by...

Evaluation of Activity Levels, Inflammatory Markers, and Overall Wellness.

The purpose for this protocol is to perform a double-blind, randomized, placebo-controlled, parallel-arm clinical study in healthy subjects to evaluate the efficacy of a nutraceutical prod...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

Companies [1296 Associated Companies listed on BioPortfolio]

Pear Therapeutics

Pear Therapeutics is the leader in prescription digital therapeutics. The company’s approach is to integrate clinically-validated software applications with previously approv...

Pear Therapeutics, Inc.

Pear Therapeutics is the leader in prescription digital therapeutics. We aim to redefine medicine by discovering, developing, and delivering clinically validated software-based th...

Pear Bureau Northwest

Pear Bureau Northwest is the non-profit marketing organization established in 1931 to promote the fresh USA Pears grown in Washington and Oregon. Together, these two states represent 1,600 growers and...

PEAR Sports, LLC

Developed by a passionate team of entrepreneurs with athletic, technology and design backgrounds, PEAR Sports was born from the desire to offer game-changing personalized coaching...

California Pear Advisory Board

More Information about "Pear Therapeutics, Inc." on BioPortfolio

We have published hundreds of Pear Therapeutics, Inc. news stories on BioPortfolio along with dozens of Pear Therapeutics, Inc. Clinical Trials and PubMed Articles about Pear Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pear Therapeutics, Inc. Companies in our database. You can also find out about relevant Pear Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record